Increased qualitative and quantitative requirements put on haematopoietic cell establishments as the result of the covid-19 pandemic - own experience
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F21%3A10438978" target="_blank" >RIV/00179906:_____/21:10438978 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11150/21:10438978
Výsledek na webu
<a href="http://dx.doi.org/10.18462/iir.cryo.2021.0043" target="_blank" >http://dx.doi.org/10.18462/iir.cryo.2021.0043</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.18462/iir.cryo.2021.0043" target="_blank" >10.18462/iir.cryo.2021.0043</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Increased qualitative and quantitative requirements put on haematopoietic cell establishments as the result of the covid-19 pandemic - own experience
Popis výsledku v původním jazyce
The haematopoietic cell establishment of the Tissue Establishment of the University Hospital Hradec Králové (EU TE Code CZ000426) has been providing cryopreserved haematopoietic progenitor cell (HPCs) concentrates for autologous transplantation for several decades. The total of 140 - 220 autologous cryopreserved HPC units per year were delivered for clinical application in the years 2015 - 2019. Cryopreservation of allogeneic HPCs was limited to rare cases, in which coordination of the HPC harvest in the donor and the preparation of the patient for transplantation was not possible. At the beginning of the COVID-19 pandemic the fluent transport of allogeneic HPC grafts in the global scale was jeopardized by restrictions of crossing the state borders. For this reason, the European Commission gave the transport of substances of human origin (SOHO) the absolute priority. In the same time the European Group for Bone Marrow and Blood Transplantation (EMBT) issued a recommendation to cryopreserve all allogeneic HPC concentrates. Cryopreservation was performed by us in 14 unrelated HPC collections, countries of origin were Czech Republic (n = 3), FRG (n = 7), Poland (n = 2), Switzerland (n = 1), Turkey (n = 1) and in 5 related HPC collections in the year 2020. All cryopreserved HPC concentrates were found suitable for clinical application and the total of 111 units were transplanted. The total number of cryopreserved HPC units transplanted in 2020 including 205 autologous ones was 316, which is approximately 200 % of the number of units transplanted in the previous year 2019.
Název v anglickém jazyce
Increased qualitative and quantitative requirements put on haematopoietic cell establishments as the result of the covid-19 pandemic - own experience
Popis výsledku anglicky
The haematopoietic cell establishment of the Tissue Establishment of the University Hospital Hradec Králové (EU TE Code CZ000426) has been providing cryopreserved haematopoietic progenitor cell (HPCs) concentrates for autologous transplantation for several decades. The total of 140 - 220 autologous cryopreserved HPC units per year were delivered for clinical application in the years 2015 - 2019. Cryopreservation of allogeneic HPCs was limited to rare cases, in which coordination of the HPC harvest in the donor and the preparation of the patient for transplantation was not possible. At the beginning of the COVID-19 pandemic the fluent transport of allogeneic HPC grafts in the global scale was jeopardized by restrictions of crossing the state borders. For this reason, the European Commission gave the transport of substances of human origin (SOHO) the absolute priority. In the same time the European Group for Bone Marrow and Blood Transplantation (EMBT) issued a recommendation to cryopreserve all allogeneic HPC concentrates. Cryopreservation was performed by us in 14 unrelated HPC collections, countries of origin were Czech Republic (n = 3), FRG (n = 7), Poland (n = 2), Switzerland (n = 1), Turkey (n = 1) and in 5 related HPC collections in the year 2020. All cryopreserved HPC concentrates were found suitable for clinical application and the total of 111 units were transplanted. The total number of cryopreserved HPC units transplanted in 2020 including 205 autologous ones was 316, which is approximately 200 % of the number of units transplanted in the previous year 2019.
Klasifikace
Druh
D - Stať ve sborníku
CEP obor
—
OECD FORD obor
30205 - Hematology
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název statě ve sborníku
Cryogenics 2021 online. The 16th Cryogenics 2021 IIR International Conference, October 5-7, 2021. Proceedings
ISBN
978-2-36215-047-0
ISSN
0151-1637
e-ISSN
—
Počet stran výsledku
5
Strana od-do
173-177
Název nakladatele
International Institute of Refrigeration
Místo vydání
Paris
Místo konání akce
Czech Republic
Datum konání akce
5. 10. 2021
Typ akce podle státní příslušnosti
WRD - Celosvětová akce
Kód UT WoS článku
001304907400022